Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:35 PM EDT

Kamada (KMDA) Tax Provisions (2012 - 2026)

Kamada's (KMDA) quarterly Tax Provisions came in at -$927000.0 in Q2 2026, down 157.12% on a YoY basis from $1.6 million in Q2 2025, and up 26.37% quarter-over-quarter from -$1.3 million in Q1 2026.

Analysis

Kamada (KMDA) Tax Provisions (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Tax Provisions for 13 consecutive years, with -$927000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Tax Provisions fell 157.12% year-over-year to -$927000.0; the trailing twelve-month figure through Jun 2026 stood at -$4.4 million (down 1953.14% YoY), and the FY2025 full-year result was -$3.3 million, down 389.8% from the prior year.
  • Tax Provisions grew to -$927000.0 in Q2 2026 per KMDA's latest filing, from -$1.3 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $1.6 million in Q2 2025 and bottomed at -$2.6 million in Q1 2025.
  • Historically, Tax Provisions has averaged -$225111.1 across 5 years, with a median of $5500.0 in 2022.
  • The sharpest annual moves came in 2024 and 2025: Tax Provisions surged 3867.65% in 2024, then sank 3479.73% in 2025.
  • Over 5 years, Tax Provisions stood at $2000.0 in 2022, then soared by 1600.0% to $34000.0 in 2023, then soared by 3867.65% to $1.3 million in 2024, then sank by 186.88% to -$1.2 million in 2025, then advanced by 20.9% to -$927000.0 in 2026.
  • According to Business Quant data, Tax Provisions over the past three periods registered -$927000.0, -$1.3 million, and -$1.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Amgen 211.77 Bn 197.79 Bn 7.24 Bn 393.00 Mn
2 Gilead Sciences 181.13 Bn 177.95 Bn 6.22 Bn 242.00 Mn
3 Vertex Pharmaceuticals 132.24 Bn 124.39 Bn 2.84 Bn 292.00 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.89 Bn 3.93 Bn 230.90 Mn
5 Argenx Se 61.56 Bn 56.38 Bn 1.37 Bn -59.00 Mn
6 Moderna 54.38 Bn 49.24 Bn 52.00 Mn 15.00 Mn
7 Alnylam Pharmaceuticals 34.44 Bn 31.13 Bn 992.69 Mn 13.31 Mn
8 Biogen 31.17 Bn 29.89 Bn 1.96 Bn 34.90 Mn
9 Roivant Sciences 30.12 Bn 30.12 Bn 1.16 Mn -3.96 Mn
10 Kamada 473.28 Mn 403.14 Mn 22.47 Mn -927,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -927,000.00
Mar 31, 2026 -1.26 Mn
Dec 31, 2025 -1.17 Mn
Sep 30, 2025 -1.07 Mn
Jun 30, 2025 1.62 Mn
Mar 31, 2025 -2.65 Mn
Dec 31, 2024 1.35 Mn
Sep 30, 2024 -84,000.00
Jun 30, 2024 -63,000.00
Mar 31, 2024 -74,000.00
Dec 31, 2023 34,000.00
Sep 30, 2023 73,000.00
Jun 30, 2023 93,000.00
Mar 31, 2023 13,000.00
Dec 31, 2022 2,000.00
Sep 30, 2022 10,000.00
Jun 30, 2022 9,000.00
Mar 31, 2022 41,000.00
Dec 31, 2020 281,000.00
Sep 30, 2020 348,000.00